KEY FINDINGS The Asia-Pacific rat model market is anticipated to grow at a CAGR of 9.13 % for the forecast period of 2019-2027 and is expected to generate a revenue of $XX thousand by the year 2027. The rising demand for research activities in the Asia-Pacific countries has increased the opportunities for this market by many folds.
MARKET INSIGHTS The Asia-Pacific market is rapidly flourishing because of major drivers like supportive R&D incentive schemes for Contract Research Organizations, biotechnological complies and the booming pharmaceutical sectors in regional countries such as Australia, India and China.Presently, India has the third largest pharmaceutical industry in the world whereas, China is presently the second largest investor in research & development globally, and is expected to overtake US research & development investments by the year 2023.
The toxicology application is dominating the current market scene.However, the oncology market is fast growing owing to the increasing number of cancer cases worldwide and is estimated to grow at a CAGR of xx % by 2027.
On the basis of the market segmentation by type, the genetically engineered outbred type is seemingly a fast emerging market growing at a CAGR of xx% whereas the other types such as surgically modified rats, inbred, hybrid and immune-deficient rats are expected to grow at a CAGR of xx%, xx%, xx% and xx% respectively over the forecast period. By the market segmentation by component, the services sector is predicted to lead the market and is predicted to grow faster at a CAGR of xx% by the end of the forecast period.
COMPETITIVE INSIGHTS The leading companies players in the Asia-Pacific Rat Model market are Taconic Biosciences, Transviragen Inc., Transposagen Biopharmaceuticals Inc., Charles River Laboratories Inc., Laboratory Corporation of America Holdings, Vivo Biotech Ltd., Cyagen Biosciences Inc., Genoway S.A., Sage Labs Inc. (Acquired By Horizon Discovery Group PLC), Hera Biolabs Inc., Envigo, Biomere, Clea Japan, Janvier Labs and Oncodesign S.A.
Companies mentioned 1. BIOMERE 2. CHARLES RIVER LABORATORIES INC. 3. CLEA JAPAN 4. CYAGEN BIOSCIENCES INC. 5. ENVIGO 6. GENOWAY S. A. 7. HERA BIOLABS INC. 8. JANVIER LABS 9. LABORATORY CORPORATION OF AMERICA HOLDINGS 10. ONCODESIGN S.A. 11. SAGE LABS INC. (ACQUIRED BY HORIZON DISCOVERY GROUP PLC.) 12. TACONIC BIOSCIENCES 13. TRANSPOSAGEN BIOPHARMACEUTICALS INC. 14. TRANSVIRAGEN INC. 15. VIVO BIOTECH LTD.
Our reports have been used by over 10K customers, including:
120 pages •
By Infiniti Research Limited
• Dec 2020
Global Rabies Treatment Market 2020-2024 The analyst has been monitoring the rabies treatment market and it is poised to grow by $ 1.06 bn during 2020-2024, progressing at a CAGR of 5% during the forecast period. Our report on rabies treatment market provides a holistic analysis, market size and forecast, trends, growth...
“Ilaris- Drug Insight and Market Forecast – 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Ilaris in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2017–2030 is...
Colitis Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Colitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Colitis Clinical trials scenario.This report provides top line data relating to the clinical trials on Colitis. Report...
Cyclin Dependent Kinase 2 - Pipeline Review, H2 2020 Summary Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Cyclin-dependent kinase 2 is an enzyme encoded by the CDK2 gene. CDK2 is the catalytic subunit of the cyclin-dependent protein kinase...
200 pages •
By The Business Research Company
• Nov 2020
Bi-Specific MAbS Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global bi-specific mabs market. This report focuses on bi-specific mabs market which is experiencing strong growth. The report gives a guide to the...
The Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2020 report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer monoclonal antibody partnering deals Most active companies...
Neurofibromatoses Type II - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Neurofibromatoses Type II - Pipeline Review, H2 2020, provides an overview of the Neurofibromatoses Type II (Genetic Disorders) pipeline landscape. Neurofibromatosis...
Monoclonal Antibody Therapeutics Market Research Report by Source (Chimeric, Human, and Humanized), by End User (Hospitals, Private Clinics, and Research Institute), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.